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Probiotic supplementation in trained trotter horses: effect on blood
clinical pathology data and urine metabolomic assessed in field. J
Appl Physiol 125: 654–660, 2018. First published April 19, 2018;
doi:10.1152/japplphysiol.01131.2017.—The attention of sports com-
munity toward probiotic supplementation as a way to promote exer-
cise and training performance, together with good health, has in-
creased in recent years. This has applied also to horses, with prom-
ising results. Here, for the first time, we tested a probiotic mix of
several strains of live bacteria typically employed for humans to
improve the training performance of Standardbred horses in athletic
activity. To evaluate its effects on the horse performance, we mea-
sured lactate concentration in blood, a translational outcome largely
employed for the purpose, combined with the study of hematological
and biochemical parameters, together with urine from a metabolomics
perspective. The results showed that the probiotic supplementation
significantly reduced postexercise blood lactate concentration. The
hematological and biochemical parameters, together with urine mo-
lecular profile, suggested that a likely mechanism underlying this
positive effect was connected to a switch of energy source in muscle
from carbohydrates to short-chain fatty acids. Three sulfur-containing
molecules differently concentrated in urines in connection to probi-
otics administration suggested that such switch was linked to sulfur
metabolism.
NEW & NOTEWORTHY Probiotic supplementation could reduce
postexercise blood lactate concentration in Standardbred horses in
athletic activity. Blood parameters, together with urine molecular
profile, suggest the mechanism underlying this positive effect is
connected to a switch of energy source in muscle from carbohydrates
to short-chain fatty acids. Sulfur-containing molecules found in urines
in connection to probiotics administration suggested that such switch
was linked to sulfur metabolism.
exercise; lactate; probiotics; Standardbred horse; urine metabolomics
INTRODUCTION
The attention of sports community toward probiotic supple-
mentation as a way to promote exercise and training perfor-
mance, as well as good health, has increased in recent years
(46, 59). As many as over 700 randomized, controlled, human
studies have been conducted with probiotics already in 2011
(56), mainly focusing on gastrointestinal conditions but also
included allergic, metabolic, inflammatory, and respiratory
conditions. Indeed, in human athletes, probiotic supplementa-
tion was found to reduce gut permeability, decrease incidence
and severity of respiratory diseases, modulate cytokines pro-
duction, and increase plasma antioxidant (25, 33, 34, 40, 58,
59). Unfortunately, these studies have been criticized for sug-
gesting a too ample spectrum of incoherent biomarkers of
immunological, physiological, and health benefits. Moreover,
the studies have been generally found to lack a practical
perspective, consisting of translational outcomes or clinical
benefits that could be applied by athletes and coaches (46).
Research about probiotics as a way to improve health status,
and in turn performance, has focused also on horses, with
promising results (1, 21, 24, 48). Unfortunately, the ambiguity
of the results seems to affect also the choice of the formulations
to be employed in horses, mainly due to the loosely regulated
quality of commercial over-the-counter products, together with
incoherence in the selection of strains and dosages (50). In
addition, many of the formulations increasingly used for horses
have been originally designed for humans. This means that any
evidence obtained on humans may not be straightforwardly
valid for horses. This is specifically true for the genera most
commonly used in human probiotic formulations, namely Lac-
tobacillus, Bifidobacterium, and Enterococci, the presence of
which in the horse microbiota is limited (11, 13, 14, 50).
In this context, additional research about specific probiotics
for use in horses is highly needed for at least three main
reasons. First, the safety and absence of side effects of the
administration to horses of probiotic formulations originally
designed for humans must be assessed. This first safety assess-
ment would allow to by-pass the need for a specific horse
formulation reducing the costs of elaboration. Second, it must
still be proven whether “human” probiotic strains are able to
colonize horses’ intestinal tract. This would confirm the pos-
sibility to utilize bacterial strains selected according to their
probiotic properties and not their origin (49); third, it must be
demonstrated if and to what extent probiotics may influence
horses’ training performance. This information is much more
limited for horses than for humans (50).
In the present work, we investigated the possibility to use a
high concentration multispecies probiotic formulation typically
employed for humans to improve the training performance of
Standardbred horses. For the purpose, we measured lactate
concentration in blood, a translational outcome largely em-
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ployed for performance. We flanked this observation with the
study of urine from a metabolomics perspective, allowing an
overall picture of the reaction of the body to exercise (12) and
to conditions having direct consequences on the inflammatory
status of the body (3, 19), which is often altered by intense
exercise (43).
MATERIALS AND METHODS
Ethical issue. All the described animal-related procedures were
conducted according to Directive 2010/63/EU of the European Par-
liament and of the Council of 22nd September 2010 on the protection
of animals used for scientific purposes (Article 1, Paragraph 1, Letter
b) and the Italian legislation (D. Lgs. n. 26/2014, Article 2, Paragraph
1, Letter b). The study received the approval of the Ethics Committee
of Camerino University (Protocol No. E81AC.8/bis).
Animals. Ten Standardbred horses (4 male and 6 female) were
included in the study. The age of the horses ranged between 3 and 8
yr (median 6.5 yr), and the weight was between 405 and 511 kg
(median 479 kg). All horses were in activity at the time of the trials
and, once enrolled, were stabled in boxes and subjected to a standard-
ized diet composed by hay (a mix of ryegrass and wild oats),
complementary feed (containing a mix of oats, barley, wheat, and
alfalfa pellets) twice a day (2.5 and 1% of live weight, respectively,
divided in 2 rations), and water ad libitum (36). All animals had been
dewormed at least 3 mo before the study with a commercial product
containing a mix of ivermectine (200 ng/kg body wt) and praziquantel
(1.5 mg/kg body wt) and, according to Italian rules, vaccinated against
influenza and tetanus. All horses were clinically checked for muscular
and respiratory diseases and endoscopically controlled for upper
airway dysfunctions.
Animals were clinically checked every day to assess the presence
of one of the following conditions causing the exclusion from the
study: adverse reaction to the probiotic (e.g., allergy, gastrointestinal
symptoms), need for other drugs, dyspnea, anorexia/disorexia, weight
loss, nasal discharge, cough, fever, diarrhea, and lameness.
Experimental design. The study was designed as a randomized,
double-blinded, placebo-controlled trial with crossover and was con-
ducted in the same racetrack where the horses were housed. The
length of the ovoid track was 800 m and made in dry quarry material
with the superficial finishing coat in calcareous sand.
Each horse was conducted always by the same driver, using similar
standard sulky for competitions.
Before the study, the animals were conditioned for 21 days to daily
training sessions of standardized exercise, identical to the training
used for the trials described in the following sections. The study was
then conducted for 84 days divided in four equal and consecutive
training periods lasting 21 days. Each 21-day training period was
identical for all horses and consisted of alternated type A and type B
training exercises, following the schedule reported in Table 1 with
exercise B intended as submaximal effort. Training sessions were
always performed in the morning, immediately after consumption of
the first food ration of the day.
After 21 days of exercise conditioning, the horses were randomly
divided into two groups of five subjects each: group 1 was treated
with food supplemented with Slab51 probiotic mixture for 21 days;
and group 2 was fed with placebo for 21 days. In detail, 17.5 g of
probiotic/placebo were administered twice a day directly in the mouth
of the horse using a tube dozer.
After a washout period of 21 days, the two groups were reversed so
that placebo was administered to group 1, and probiotics were
administered to group 2 for an additional 21 days. The activity
performed during the clinical trial is illustrated in Fig. 1.
All sampling and clinical evaluations were performed at rest in the
morning, 1 h after the end of the feeding, with the exception of lactate
evaluation that was performed before starting the exercise and as soon
as the horse returned to the box, immediately after the exercise.
Probiotic and placebo composition. The probiotic mixture chosen
for the present investigation is a mix of 8 bacterial strains of live lactic
acid bacteria and bifidobacteria (probiotic mix Slab51: Lactobacillus
acidophilus DSM32241, L. plantarum DSM32244, L. casei DSM
32243, L. helveticus DSM 32242, L. brevis DSM27961, Streptococcus
thermophilus DSM 32245, Bifidobacteria lactis DSM 32246, and B.
lactis DSM32247), with the addition of excipients such as maltose and
silicon dioxide (Sivoy; Mendes). The placebo was a powder contain-
ing only maltose and silicon dioxide as inactive ingredients and was
stored in bottles identical to the active product.
Sampling of venous blood. Venous blood samples were collected at
rest from the jugular vein into sterile tubes with and without EDTA at
T0 (before start of administration) and T1 (at the end of the 21 days
of Slab51/placebo administration). With the exception of lactate
evaluation, the T1 sampling was performed 12 h after the end of the
daily exercise to avoid the effect of the effort on hematological and
biochemical parameters (e.g., exercise-induced dehydration, spleen
contraction).
The following hematologic parameters were assessed within 12 h
from EDTA sample collection, using an hematological cell counter
Table 1. Daily exercise of horses for each training session
Type of Exercise Activities Day
Exercise A 400-m walk
400-m light trot
3,800-m medium trot
1, 2, 4, 5, 6, 8, 9, 11, 12,
13, 15, 16, 18, 19, 20
Exercise B 400-m walk
400-m light trot
3,800-m fast trot
3, 7, 10, 14, 17, 21
Fig. 1. Schedule of the clinical trials activity.
T0, before treatment. T1, after treatment.
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(Cell Dyn 3500, Abbott): erythrocytes (red blood cells), packed cell
volume, hemoglobin, red cell distribution width, mean corpuscular
volume, mean corpuscular hemoglobin, mean corpuscular hemoglo-
bin concentration, total leukocytes, neutrophils, lymphocytes, mono-
cytes, eosinophils, basophils and platelets, and mean platelet volume.
Biochemical profile was assessed on serum samples using a spectro-
photometer BT 3000 plus (Biotecnica Instruments, Rome, Italy) and
included aspartate aminotransferase, -glutamyl transferase, creatin-
phosphokinase, total protein, albumin, globuline, urea, creatinine,
glucose, alkaline phosphstase, lactate dehydrogenase, total bilirubin,
direct bilirubin, triglycerides, cholesterol, calcium, phosphorus, mag-
nesium, sodium, potassium, and chlorine.
Blood lactate concentration was tested on whole blood using a
portable device (Accutrend Plus; Roche, Mannheim, Germany) both
at T0 and T1 immediately before (pre) and after (post) the exercise of
the respective day.
Urine collection and analysis. Urine was collected before (pre) and
after (post) each training session both at T0 and at T1 during
spontaneous urination, using a stick connected with a sterile 50 ml
Falcon tube containing sodium azide, directed under the urine flow at
the time of urination. Urine was frozen at 80°C within 2 h after
collection.
Urine samples were prepared for proton nuclear magnetic reso-
nance (1H-NMR) analysis by modifying the protocol described by
Barbara et al. (3). Briefly, each sample was centrifuged for 15 min at
15K rpm and 4°C. Then, 0.3 ml of supernatant were added to 0.3 ml
of bidistilled water and 0.2 ml of a D2O solution of 3-(trimethylsilyl)-
propionic-2,2,3,3-d4 acid sodium salt (10 mM). The solution obtained
was centrifuged as previously described. 1H-NMR spectra were re-
corded at 298 K with an AVANCE III spectrometer (Bruker, Milan,
Italy) operating at a frequency of 600.13 MHz. Following Ventrella et
al. (55), the signals from broad resonances originating from large
molecules were suppressed by a CPMG filter composed by 400
echoes with a  of 400 s and a 180° pulse of 24 s for a total filter
of 330 ms. The HOD residual signal was suppressed by means of
presaturation. This was done by employing the cpmgpr1d sequence,
part of the standard pulse sequence library. Each spectrum was
acquired by summing up 256 transients using 32-K data points over a
7,184-Hz spectral window, with an acquisition time of 2.28 s. By
following Bryszewska et al. (5), to apply NMR as a quantitative
technique, the recycle delay was set to 5 s, keeping into consideration
the relaxation time of the protons under investigation. The signals
were assigned by comparing their chemical shift and multiplicity with
literature (15), the Human Metabolome Database (60), and Chenomx
software library (ver 8.1; Chenomx).
Statistical analysis. Statistical analysis was conducted in R com-
putational language (47). Both pretraining and posttraining, each
parameter was influenced on one side by the administration of placebo
or treatment (a within subjects variable) and on the other side by the
horse (a between subjects variable) (8). The paired nature of the latter
variable was taken into consideration by means of a Kruskal-Wallis
test for repeated measurements. For the purpose, the aov function of
the R package “stats” (7) was applied on the parameters expressed as
ranks (10). To circumvent in part the dichotomous application of
P values, as suggested by Greenland et al. (27) and Wehrens and
Franceschi (57), a P value trim limit of 0.1 was considered, in
agreement with Kang et al. (32).
To partially account for the natural variability of each parameter,
the samples obtained at the two T0 points, together with the sample
obtained after placebo administration, were considered as describing
the animal under no treatment. This choice was based on the rationale
that a specific effect ascribable to placebo has never been observed in
horses (41). Moreover the mechanism of administration of the probi-
otic mixture and the fully crossed experimental design were unlikely
to lead to any noticeable placebo induced reaction in the animal.
Any correlation among the parameters studied in the present
investigation was looked for by calculating their Spearman’s rank
correlation coefficient, which were considered significant for P 
0.05. To remove outliers, a three steps approach was followed. First,
each couple of variables was employed to calculate a robust principal
component analysis (31) model. Second, the samples’ scores along PC
2 of the corresponding scoreplot were scaled to unity variance. Finally
samples were considered as outliers when their score differed more
than two standard deviations from the mean.
RESULTS
No adverse reaction was observed during the trial, and no
animal was excluded from the study after clinical and endo-
scopic assessments.
To understand whether there was a connection between
probiotics administration and resistance of the horses to the
effort caused by training, we decided to focus on the concen-
tration of lactate in the blood before and after the daily
exercise. Taking into account the natural fluctuations in the
concentration of this molecule as a result of postprandial
conditions and other confounding factors, we considered the
samples obtained at the two T0 points, together with the
sample obtained after placebo administration, as describing
the animal under no treatment, as outlined in Fig. 2.
Before all training sessions, the horses showed a similar
blood lactate concentration, equal to 2.0  0.9 mmol/l. Post-
training, every horse but those at T1 treated with probiotics
showed again a similar value of lactate, equal to 13.0  1.8
mmol/l. On the opposite, horses at T1 treated with probiotics
showed posttraining a blood lactate concentration of 9.9  1.9
mmol/l, significantly lower than the other groups observed
posttraining.
Results concerning hematological and biochemical parame-
ters are reported in Tables 2 and 3, respectively.
Fig. 2. Blood lactate concentration in horses before (T0) or after (T1) treatment
with probiotics (Prob) and placebo (Pbo), and pre- and posttraining. Samples
obtained at T0 and after treatment with placebo were considered as constituting
a single group (white boxplots). Samples obtained after treatment with probi-
otics (gray boxplots) were compared with them by nonparametric univariate
analysis test (P values).
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Among hematological parameters, mean corpuscular hemo-
globin and red cell distribution width coefficient showed lower
values for samples obtained at the end of probiotics adminis-
tration with high significance (P  0.05). Two other parame-
ters, hematocrit and mean corpuscular hemoglobin concentra-
tion, had higher values at the end of probiotics administration
in the horses considered but only with scarce significance (P 
0.1). Among biochemical parameters, only calcium concentra-
tion showed highly significant differences (P  0.05) between
the two identified groups of samples.
The investigation of the impact of probiotics supplementa-
tion was then extended to urine metabolome before the daily
exercise. The molecules that could be quantified pertained
mainly to the chemical groups of amino acids, short chain fatty
acids, organic acids, and monomeric carbohydrates (15). The
molecular profile for probiotics at T1 differed from the others
in the concentration of eight molecules (Table 4).
Figure 3 reports the hematological or biochemical parame-
ters and the molecules listed in Tables 2, 3, and 4 that showed
a correlation with lactate concentration registered postexercise.
DISCUSSION
The specific probiotic formulation used in this study did not
cause any adverse reactions in the horses. Animals were daily
monitored throughout the study, and no clinically evident side
effect was registered. Furthermore, the changes found in he-
matological and biochemical parameters cannot be associated
with modifications of the metabolism, which would negatively
affect the sanitary status of the animal. It can therefore be
concluded that the tested probiotic formulation does not cause
any detrimental effect and can be safely used in horses.
Blood lactate response to exercise can be used in field test
for assessing performance and fitness, because it reflects the
reduction of lactic acid production and accumulation in mus-
cular cells, with direct consequences on the onset of fatigue in
athletic horses (12, 24, 48). Postexercise, the blood lactate
concentration was statistically lower in horses treated with
probiotics than in the other groups. Lactate accumulation in
muscles can lead to impairment of glycolysis and respiratory
capacity of mitochondria (the main source of plasmatic AST)
(30), decreasing in ATP concentration and availability, and to
sarcoplasmic reticulum swelling (29, 53). These mechanisms
are the basis of the onset of fatigue in athletic horses (28). This
is why lactate concentration in blood, reflecting the one in
muscles, is largely employed as an index of performance, also
because it is considered as more reliable than oxygen consump-
tion rate and heart beat (26). Lactate accumulation is usually
evaluated by measuring the VLa4 (the speed at lactate concen-
tration of 4 mmol/l): as the horse increases fitness, VLa4
increases. However, the blood lactate response to a single
episode of submaximal exercise can be used as an alternative
(16) to such method. Since a lower blood lactate concentration
has been found in the treated group after exercise, probiotics
seem to promote the performance of the athletic horses, which
could be correlated with better performance during the race.
Several mechanisms have been described that could account
for this finding, mainly focusing on the possibility for the
muscles to use short-chain fatty acids (SCFAs) instead of
carbohydrates as energy source. Lactobacilli supplementation
can modify hindgut pH and induce the proliferation of other
genus such as Veillonella spp., the most abundant lactate
utilizing bacteria in horse gut (4), modifying the energy source
during exercise. In a previous report, unconditioned horses
supplemented with yeast exhibited lower plasma lactate con-
centration than unsupplemented horses (24). The authors spec-
ulated that probiotics administration could modify gut fermen-
tation and, consequently, could increase the amount of circu-
lating SCFAs, which are efficiently used as energy source in
exercise. These findings are supported by the results obtained
by Garcia et al. (21), who found that horses receiving probi-
otics better digested hemicelluloses. In a previous work,
Medina et al. (42) showed that probiotics such as Saccharo-
myces cerevisiae are able to modify production and proportion
of SCFAs in the large intestine. This could make the horses use
a lower amount of carbohydrates, which would account for the
lower production of muscular lactic acid observed in the
present study. In horses receiving probiotic, Art et al. (1) found
that carbohydrate aerobic enzymatic capacity and carbohy-
drate utilization are improved. Furthermore, oral adminis-
tration of Lactobacillus plantarum showed to have a poten-
tial for the removal and utilization of blood lactate after
exercise in mice (9).
The idea of a profile modification of the molecules employed
by the horse muscles as energy source seems to be supported,
in the present paper, by the metabolomics observation of urine
preexercise. The concentration of trans-aconitate, in particular,
was found to be significantly modified by the administration of
probiotics and was found to correlate with lactate concentration
in blood postexercise. Trans-aconitate offers an insight into
TCA cycle, as this molecule is endogenously originating from
the cycle’s intermediates, through cis-aconitate, by means of
trans-aconitate decarboxylase (23). As a confirmation, the
concentration of trans-aconitate in human urines proved to be
modified by exercise sessions (45).
Citrate concentration trend pairs the one of trans-aconitate in
giving information about TCA cycle efficiency in the horses
under investigation. Indeed, the citrate concentration in urine
can be considered as an indirect biomarker of the horses
Table 3. Biochemical parameters pretraining
T0 or T1 Placebo
Treatment
T1 Probiotics
Treatment P
AST, U/l 340.07  57.30 310.40  42.57 0.0913
Albumin, g/dl 3.19  0.27 3.53  0.19 0.0650
Triglycerides, mg/dl 22.07  6.03 21.90  6.52 0.0874
Total calcium, mg/dl 11.14  1.41 11.82  1.45 0.0194
Phosphorus, mg/dl 4.11  1.35 4.93  1.29 0.0547
Values are means  SD. For readability reasons, only comparisons charac-
terized by P  0.1 are reported. AST, aspartate aminotransferase.
Table 2. Hematological parameters pretraining
T0 or T1 Placebo Treatment T1 Probiotics Treatment P
HCT, % 39.70  4.35 41.20  3.10 0.0692
MCH, pg 16.30  1.33 15.40  1.31 0.0283
MCHC, g/dl 32.80  1.55 32.90  1.71 0.0995
RDWc, % 21.60  0.79 21.20  0.62 0.0452
Values are means  SD. For readability reasons, only comparisons charac-
terized by a P  0.1 are reported. HCT, hematocrit; MCH, mean corpuscular
hemoglobin; MCHC, mean corpuscular hemoglobin concentration; RDWc, red
cells distribution width coefficient.
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training status. In fact, endurance training is known to modu-
late the concentration in mitochondria of citrate synthase en-
zyme (51), which in turn modulates the concentration of TCA
intermediates. Morevoer, evidence gathered in humans shows
that citrate is excreted with urines at lower levels in trained
subjects (37).
The trend evidenced for triglycerides concentration in blood
seems to offer a different prospective of the same phenomenon.
In fact, the decreasing trend of triglycerides in blood connected
to probiotics supplementation could also be attributed to the
accumulation of SCFAs that pass from the lumen into the
bloodstream regulate the balance in fatty acids synthesis (6, 9,
22). Indeed, a similar effect of Lactobacillus plantarum has
also been found in experimental exercise mice and other
laboratory animals (9, 44) and could also occur in horses.
To better characterize the underlying reasons for the energy
switch that seems to be observed in the present investigation,
urine taurine, p-cresol sulfate, and dimethyl sulfone offer a
compelling clue for reflection. Among the molecules charac-
terized by urine metabolomics, these are the only ones that
contain sulfur and their concentration was found to be altered
by probiotic administration. Moreover, p-cresol sulfate and
taurine have also been found positively correlated to lactate
concentration in blood postexercise, as shown in Fig. 3. These
molecules seem therefore to suggest that sulfur metabolism
may play a role in the highlighted energy metabolism changes.
These molecules are actually noteworthy per se in the present
context. The nonproteogenic amino acid taurine plays a pivotal
role in skeletal muscle development (38) and high excretion of
it through urine has even been associated to disuse-related
muscle atrophy. P-cresol sulfate seems to be doubly linked to
body inflammatory status, so that its low concentration in urine
seems to be desirable. P-cresol sulfate is found in urine solely
as a result of colon bacteria catabolism of food components
that escape digestion (17). In particular, its production has been
linked to disordered bacterial colonization in inflammatory
bowel disease (20). Despite the inconclusive and sometimes
misunderstood literature (54), p-cresol sulfate is considered
as exerting a toxic effect on the body at several levels, thus
leading to systemic inflammation (35). Dimethyl sulfone has
been found to protect horses from systemic inflammation
connected to exercise injuries (39), probably by exerting a
scavenging effect on reacting oxygen species, so that it may
even be employed as a horse food additive.
Other parameters were statistically influenced by probiotics
administration, although not clinically relevant, such as cal-
cium and phosphorus with trends linked to SCFAs production,
which can modulate both their release and absorption (52). The
lower detection of aspartate aminotransferase in the probiotic
group after exercise suggests a beneficial effect of probiotics
on muscular cell preservation, due to the controlled intracellu-
lar lactic acidosis under the effects of the mechanisms previous
described (6, 9, 18).
The link between gut microbiota and catecholamines has
been demonstrated in mice (2) and, in the author’s opinion, the
significant hematocrit increase in the probiotic group should be
considered related to a more vigorous adrenergic effect caused
by catecholamines production, as suggested by other authors
(61). The rise in hematocrit leads to an increase of red cells
number in bloodstream and could therefore contribute to a
better oxygenation of tissues and, consequently, to a more
proficient utilization of aerobic pathways.
Conclusion. The results of the present study show that
probiotic supplementation could reduce postexercise blood
lactate concentration in Standardbred horses in athletic activ-
ity.
The tested hematological and biochemical parameters, along
with urine molecular profile, suggest that a likely mechanism
underlying this positive effect is connected to a switch of
energy source in muscle from carbohydrates to SCFAs.
Table 4. Concentration of the molecules with concentration pretraining varying because of probiotic supplementation
T0 or T1 Placebo Treatment T1 Probiotics Treatment P
2-Hydroxyisovalerate 1.83  102  1.64  102 1.37  102  1.35  102 0.0469
Trans-aconitate 3.09  101  2.45  101 1.67  101  7.38  102 0.0451
Citrate 1.25  101  2.43  101 9.71  102  4.13  102 0.0733
P-cresol sulfate 3.60  102  1.72  102 2.79  102  1.81  102 0.0756
Dimethyl sulfone 3.90  101  2.64  101 5.05  101  3.03  101 0.0462
Glycine 8.28  101  1.47 2.93  101  1.16  101 0.0204
Pantothenate 1.60  101  3.61  102 1.72  101  3.83  102 0.0550
Taurine 3.23  2.23 2.16  1.38 0.0036
Values are means  SD (in mM). For readability reasons, only comparisons characterized by P  0.1 are reported.
Fig. 3. Significant correlations (P  0.05) with lactate concentration registered
postexercise of the hematological or biochemical parameters and the molecules
listed in Tables 2, 3, and 4. MCH, mean corpuscular hemoglobin; MCHC, mean
corpuscular hemoglobin concentration; RDWc, red cells distribution width coef-
ficient.
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A possible limitation of the study could be the lack of direct
information about the real colonization of the horse gut by the
probiotic used. Further studies could better clarify this issue.
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